/PRNewswire/ -- 4E Therapeutics, Inc. ("4E"), an Austin-based neuroscience company developing next-generation treatments for chronic pain, today announced that...
Acquisition combines 4E's innovative MNK inhibitor with Lilly's broad neuroscience capabilities and portfolio
AUSTIN, Texas, June 16, 2026 /PRNewswire/ -- 4E Therapeutics, Inc. ("4E"), an Austin-based neuroscience company developing next-generation t... [2382 chars]